Eluvixtamab (AMG-330)
Revision as of 22:20, 13 June 2018 by Warner-admin (talk | contribs) (Text replacement - "Category:Drug index" to "Category:Drugs")
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3